{"id":"W2617889858","doi":"10.1016/j.breast.2017.05.004","title":"Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"F. Hoffmann-La Roche; Roche","keywords":"Medicine; Trastuzumab; Tolerability; Discontinuation; Adverse effect; Cohort; Internal medicine; Adjuvant; Syringe; Oncology; Breast cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003631379,0.000535149,0.001271143,0.0001190506,0.0001616816,0.0004958546,0.0004532497,0.0008166397,0.003164886],"category_scores_gemma":[0.003938996,0.0001949203,0.001014542,0.0001967435,0.0005416542,0.0007507856,0.0002511118,0.001800264,0.0004264338],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003407079,"about_ca_system_score_gemma":0.000377592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001724387,"about_ca_topic_score_gemma":0.0004253383,"domain_scores_codex":[0.9983279,0.001091374,0.00009823572,0.0002048019,0.0001592383,0.0001184913],"domain_scores_gemma":[0.997521,0.0009701313,0.0007177867,0.0003950422,0.0001295073,0.0002665221],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8608679,0.009727398,0.00835724,0.0007251519,0.001913797,0.0001099167,0.0001714653,0.001166547,0.0106791,0.0001289473,0.002101414,0.1040511],"study_design_scores_gemma":[0.4005317,0.5405377,0.04442436,0.0001307149,0.002447876,0.0005288168,0.00008176248,0.001937469,0.004220422,0.0004199705,0.004679795,0.00005929334],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958389,0.001540279,0.0003335771,0.0001560892,0.00005272342,0.0002933785,0.0005419605,0.00003303144,0.001210185],"genre_scores_gemma":[0.9952019,0.0008452851,0.0006104026,0.0004765747,0.0001506078,0.0003735006,0.001648791,0.0000166599,0.0006762159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003631379,"threshold_uncertainty_score":0.0192048,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05830078814096429,"score_gpt":0.3442258103662161,"score_spread":0.2859250222252518,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}